glp-1 stomach paralysis class action in michigan Medications Could Cause Paralysis. What to Know Weight loss drug makers sued

Percutaneous coronary intervention (PCI) is a common solution for treating affected coronary arteries, with over 900,000 interventions performed each year

Other frequent issues include constipation and stomach pain

Wegovy (semaglutide) activates one hormone called GLP-1, while Mounjaro (tirzepatide) activates two GLP-1 and GIP

Read the full study: Once Daily Subcutaneous Growth Hormone-Releasing Hormone Therapy Accelerates Growth in Growth Hormone-Deficient Children (JCEM 1996)

The breadth of these trials suggests Lilly sees retatrutide as a cornerstone product with applications far beyond weight loss

Ozempic is about to be old news, my colleague Yasmin Tayag wrote in 2023, just before an even more powerful obesity drug, tirzepatide, then best known as Mounjaro, was approved